From 2021 to 2023, 23% of participants developed long-COVID symptoms, with 56% of those infected in 2021 reporting symptoms for 2 years.
Plaque growth can lead to a higher risk of heart attack, stroke, and other life-threatening cardiovascular events for as long as 1 year.
Post-exertional malaise, or exercise intolerance, was seen in 36% of those with long COVID.
Get weekly COVD-19 updates in your inbox.
Catch the latest episode!
Top COVID FAQs
By CIDRAP & other experts
Read all 7 reports
A PLOS One study yesterday showed a 43% overall mortality rate for mechanically ventilated COVID-19 patients, with an even higher risk of death for patients of advanced age.
The number of drug suppliers able to deliver at least 80% of their products on time dropped 16 percentage points.
Combined data show 70% efficacy, but it was 90% when the first dose was halved.
The biggest concern is what Thanksgiving gatherings will mean for hospitals, some of which are already buckling.
One expert says Europe could experience a third wave if it repeats mistakes it made after the first wave.
The report details obstacles for more than 12 million English language learners and special education students.
Racial minorities and other at-risk children appear to have more serious outcomes.
A Dutch study late last week found reduced lung capacity in 42% of COVID-19 patients 3 months after recovery, with many patients reporting severe problems with fatigue, functional impairment, and quality of life (QoL).
Also, Pfizer and BioNTech submitted an EUA request for their vaccine, offering hope it will be available this year.
The findings may explain why COVID-19 spreads quickly and is difficult to contain.
